News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

New PDUFA Action Date Assigned for Labopharm (DDS.TO) Drug; FDA Could Rule in February


8/26/2009 6:50:09 AM

Bookmark and Share

Reuters -- Canadian drugmaker Labopharm Inc said on Tuesday that U.S. regulators have accepted its latest filing regarding the antidepressant trazodone and that a decision on the drug could come in February.

Read at Reuters
Read at PR Newswire
Read at Forbes


comments powered by Disqus
Reuters
PR Newswire
Forbes
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES